Article

Michelle Esser Discusses Two Encouraging Breast Cancer Studies

Author(s):

Michelle Esser, program manager for research and advocacy, Young Survival Coalition, discusses two encouraging studies presented during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO).

Michelle Esser, program manager for research and advocacy, Young Survival Coalition, discusses two encouraging studies presented during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a Chicago gathering of nearly 30,000 oncology professionals in May and June.

Esser was particularly encouraged by discussions surrounding ovarian suppression, surgery and bisphosphonate use in premenopausal women with breast cancer. Esser also mentions a study conducted by Hatem Abdel Azim that looked at genetic differences in breast cancer of young and older women.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.
Melanoma is a key cancer type for developing and testing immunotherapies prior to broader clinical application across other malignancies.
Image of Dr. Kumar.
Photo of a woman with shoulder-length black hair wearing a blazer
Image of a woman wearing a headband and glasses
Image of man.
Image of doctor.
Related Content